Journey Medical Corporation (DERM) vs Nkarta, Inc. (NKTX)
A side-by-side comparison of Journey Medical Corporation and Nkarta, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DERM
Journey Medical Corporation
$6.42HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NKTX
Nkarta, Inc.
$2.37HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — DERM vs NKTX
growth of $100 · dividends reinvested · last 5yDERM -29.6% (-6.8%/yr)NKTX -87.1% (-33.6%/yr)DERM compounded faster over this window
Log scale — wide-divergence pair
DERM NKTX
DERM vs NKTX: by the numbers
- •DERM is the larger company ($177M vs $169M market cap).
- •Both run net losses; NKTX's is the smaller (0.00% vs -8.95% net margin).
Metrics side by side
Valuation
| Metric | DERM | NKTX |
|---|---|---|
| P/S ratio | 2.59 | N/A |
| P/B ratio | 5.50 | 0.68 |
| EV / EBITDA | 139.82 | N/A |
Profitability
| Metric | DERM | NKTX |
|---|---|---|
| Gross margin | 62.24% | 0.00% |
| Operating margin | -13.21% | 0.00% |
| Net margin | -8.95% | 0.00% |
| ROE | -19.01% | -47.36% |
| ROIC | -5.22% | -42.11% |
Growth (annualized)
| Metric | DERM | NKTX |
|---|---|---|
| Revenue CAGR (5Y) | 6.75% | N/A |
| Total return CAGR (5Y) | N/A | -37.28% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.